RE: Patient wait for gold18 Nov 2020 10:02
Just remember...
Nothing at all has changed since this share price was at 240p, with the exception of lancet peer review.
Known all along:
1, vaccines were rapidly in development... the orange idiot predicted sooner.
2, this treatment would need to clear clinical trials before emergency use
3, we have a lot of competition
The only change really is sentiment.